Letters to the Editor
Abortion of the UVEXATE study: are we unable to evaluate cheap and well-tolerated treatments?
F. Rodrigues1, E. Vicaut2, S. Abad3
- Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France.
- Unité de Recherche Clinique, Hôpital Fernand Widal, AP-HP; Université Paris 7, France.
- Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France. sebastien.abad@avc.aphp.fr
CER9762
2017 Vol.35, N°1
PI 0175
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 27749231 [PubMed]
Received: 15/07/2016
Accepted : 20/07/2016
In Press: 07/09/2016
Published: 26/01/2017